“2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street”
March 29, 2024
“Shares of Viking Therapeutics (NASDAQ: VKTX) are up about 275% in 2023, but analysts on Wall Street think it isn’t finished climbing yet. The consensus price target on the clinical-stage biotech stock suggests a 47% gain could be up ahead….
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have more than tripled over the past six months, but Wall Street expects further gains. The consensus price target on the stock implies another 73% rise by this time next year…”
https://finance.yahoo.com/news/2-soaring-growth-stocks-could-081100448.html